Key Highlights

• The fund announced a sale of $350,000,000 of 6.100% notes due 2031.

• The offering was priced at $350M and specifically prices $350M 6.100% under the underwriting agreement.

• Registration was completed under filing No. 333- 283477 with a consortium of six underwriters.

Morgan Stanley Direct Lending Fund (NYSE: MSDL) completed a major financing transaction on June 29, 2026. The fund entered into an underwriting agreement to sell $350,000,000 of new notes, expanding its debt capacity and providing liquidity for its portfolio.

Underwriting Structure

The agreement involves MS Capital Partners Adviser Inc. As the fund’s adviser and a six-member syndicate of major banks, which will underwrite a portion of the issuance, sharing customary covenants and indemnification provisions.

Note Characteristics

The notes carry a 6.100% coupon and mature in 2031, aligning with the fund’s long-term financing strategy. The transaction involves the issuance of new notes, which will be amortized over the remaining term. Investors will receive a fixed interest rate and a clear maturity schedule.

Pricing Confirmation

The offering was priced at $350M, reflecting market confidence in the fund’s credit profile. In addition, the notes were priced $350M 6.100% under the terms of the underwriting agreement, confirming the coupon rate applied to the entire issue.

Regulatory Filing

The issuance was conducted under the fund’s effective shelf registration, which included a preliminary prospectus supplement, term sheet, and final prospectus supplement dated June 29, 2026, satisfying SEC requirements.

Market Implications

By locking in a sizable tranche of capital at a 6.100% rate, the fund bolsters its balance sheet ahead of anticipated lending activity. The participation of leading banks underscores confidence in the fund’s asset quality and risk management. The transaction adds depth to the secondary market for private credit instruments.

Investor Outlook

The new notes provide investors with a medium-term, fixed-income asset tied to the fund’s diversified loan portfolio. The $350,000,000 sale expands the fund’s funding base, potentially supporting further loan originations and portfolio growth through 2031.

 

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.